“…23 Studies evaluating complication rates in a operative-based approach for the management of obstructive choledochal stone disease report similar numbers, with complication rate ranging from 5% to 20%. 24,25 In the current study, patients initially admitted to a surgical service had significantly more complications during their index admission compared to those admitted to medicine. As these patients are also more likely to undergo an operative procedure-both cholecystectomy as a singlestaged approach as well as cholecystectomy with perioperative ERCP and/or ES-the greater complication rate for a patient admitted to a surgical team is not unexpected.…”
Despite variations in uncomplicated management of CBDS and GP, there is no difference, in long-term follow-up, in the total number of hospital days or cost for the management of CBDS or GP based on admitting team practices.
“…23 Studies evaluating complication rates in a operative-based approach for the management of obstructive choledochal stone disease report similar numbers, with complication rate ranging from 5% to 20%. 24,25 In the current study, patients initially admitted to a surgical service had significantly more complications during their index admission compared to those admitted to medicine. As these patients are also more likely to undergo an operative procedure-both cholecystectomy as a singlestaged approach as well as cholecystectomy with perioperative ERCP and/or ES-the greater complication rate for a patient admitted to a surgical team is not unexpected.…”
Despite variations in uncomplicated management of CBDS and GP, there is no difference, in long-term follow-up, in the total number of hospital days or cost for the management of CBDS or GP based on admitting team practices.
“…LCBDE is associated with successful stone clearance rates ranging from 85 to 95%, a morbidity rate of 4–16% and a mortality rate of around 0–2% [6,7]. Tai et al [34] reported that the clearance rate was 100%, and no recurrence was discovered during a mean follow-up period of 16 months. Moreover, LCBDE avoids the short-term (pancreatitis, bleeding and perforation), medium (cholangitis and recurrent stone formation) and long-term (bile duct malignancy) adverse effects of ES.…”
Background/Aims: Laparoscopic cholecystectomy (LC) combined with intraoperative endoscopic sphincterotomy (IOES) was compared to LC with laparoscopic common bile duct exploration (LCBDE) to define the best single-session minimally invasive treatment for cholecystocholedocholithiasis. Methods: Between June 2009 and December 2010, patients with gallstones and common bile duct (CBD) stones diagnosed by preoperative ultrasonography and magnetic resonance cholangiopancreatography were randomized to LC-LCBDE or LC-IOES. The primary end point was complete clearance of CBD of stones. The secondary end points were operation time, conversion rate, length of hospital stay, complications and mortality. Results: Two hundred and twenty-six patients were eligible. They were randomized to LC-LCBDE (n = 115) and LC-IOES (n = 111). There was no statistically significant difference in the success rate of CBD clearance between the two interventions (92% for LC-LCBDE vs. 97.2% for LC-IOES with a p value >0.05). There were no differences between the two groups in terms of surgical time and postoperative length of stay. Pancreatitis and bleeding sphincterotomy were significantly more prevalent in the LC-IOES group, while bile leakage and retained CBD stones were significantly more prevalent in the LC-LCBDE group. Conclusion: Both LC-IOES and LC-LCBDE were shown to be safe, effective, minimally invasive treatments for cholecystocholedocholithiasis, but the former option may be preferred when facilities and experience in endoscopic therapy exist.
“…Schreurs et al showed 75%–84% patients undergoing ERCP/EST had no symptoms with up to 70-month followup [75]. Complications of ERCP include bleeding, duodenal perforation, cholangitis, pancreatitis, and bile duct injury [76]. Moreover, ERCP is not possible in 3% to 10% of all patients [77].…”
Section: Treatmentmentioning
confidence: 99%
“…Laparoscopic exploration is very effective for clearing difficult CBD stones. Tai et al reported that the clearance rate was 100%, and no recurrence was discovered during a mean followup period of 16 months [76]. Golipour et al showed LCBDE to be an effective procedure as the initial modality of management for acute gallstone cholangitis [92].…”
Common bile duct stones (CBDSs) may occur in up to 3%–14.7% of all patients for whom cholecystectomy is preformed. Patients presenting with CBDS have symptoms including: biliary colic, jaundice, cholangitis, pancreatitis or may be asymptomatic. It is important to distinguish between primary and secondary stones, because the treatment approach varies. Stones found before, during, and after cholecystectomy had also differing treatments. Different methods have been used for the treatment of CBDS but the suitable therapy depends on conditions such as patient' satisfaction, number and size of stones, and the surgeons experience in laparoscopy. Endoscopic retrograde cholangiopancreatography with or without endoscopic biliary sphincterotomy, laparoscopic CBD exploration (transcystic or transcholedochal), or laparotomy with CBD exploration (by T-tube, C-tube insertion, or primary closure) are the most commonly used methods managing CBDS. We will review the pathophysiology of CBDS, diagnosis, and different techniques of treatment with especial focus on the various surgical modalities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.